APGAR DANMARK A/S: Financial statements 2014
CVR: 17533533
Source: annual report 2014, Danish Business Authority
01/07/2013 – 30/06/2014
APGAR DANMARK A/S (CVR 17533533) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 14,232,251 and a net result of DKK 3,005,605 compared with DKK 5,081,967 the year before. That is a decrease of 24.1% compared with the year before. Equity in the 2014 report amounted to DKK 15,609,588. The solvency ratio was 77.7%.
- Gross Profit
- DKK 14,232,251
- Profit/Loss
- DKK 3,005,605
- Equity
- DKK 15,609,588
- Total Assets
- DKK 20,089,070
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 14.2 mio. | 3 mio. | 15.6 mio. | - |
| 2013 | - | 18.8 mio. | 5.1 mio. | 19.7 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout APGAR DANMARK A/S
APGAR DANMARK A/S is a Danish company of the type Aktieselskab based in Brøndby, founded in 1993. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Christian Markussen and Stig Pieler. The board consists of Christian Markussen, Hanne Pieler, Jan Pedersen and Mette Markussen. The company is owned by PIELER GROUP A/S and MARKUSSEN MEDICAL HOLDING ApS. The company has 13 employees (2018). In 2025, the company reported a gross profit of DKK 12,125,986 and a net result of DKK -1,991,044 compared with DKK 21,676 the year before. Equity in the 2025 report amounted to DKK 10,236,447.